Category: Heel Pharmacological Index

Sulfonamid-Injeel
D 12, D 30, D 200 0.367 ml each.
Sulfonamid-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.

The sulphonamides can be described as enzyme poisons which concurrently inhibit enzyme systems in which para-aminobenzoic acid is active as coenzyme (e.g. growth factor H of yeast in Streptobact. plant.). The bacteriostatic properties of the sulphonamides are achieved, therefore, through their action as enzyme poisons, which leads, and must lead, to very many side effects, e.g. gastro-intestinal disorders, cholestasis, leucothrombopenia and possibly agranulocytosis. Sulphonamide fever can, on the one hand, be caused allergically but can also indicate serious toxic damage, such as hepatitis or haemolytic anemia. Contra-Indications for the administration of sulphonamides are: the last weeks of pregnancy, the period of lactation and the first weeks of life of the infant: danger of formation of sulphaemoglobin or methaemoglobin, as in the infant, physiologically, the methaemogiobin reductatse is not yet fully capable of functioning. In the Met-Hb-formation, a toxic metabolic product formed in the liver microsomes, p-hydroylaminobenzene sulphonamide, participates decisively. Further, this may lead to a pronounced sulphonamide allergy, indeed, in the form of sulphonamide fever (see above), but also in the form of renal and hepatic disorders (see above) and allergic skin reactions. Erythema exudativum multiforme (including in the case history) represents a contraindication for sulphonamide therapy.

Indications

The clinical pictures indicated above, especially when these arise after treatment with sulphonamides, which may have been given a considerable time previously.

Digitalis-Injeel
D 6, D 12, D 30, D 200 0.275 ml each.
Digitalis-Injeel forte S
D 4, D 6, D 12, D 30, D 200 0.220 ml each.

Pulse weak and slow (in this case, not the Injeel-forte), cyanosis (lips, tongue, etc.), traumatism resulting from falls, nausea, enlarged liver, urinary disorders.

Magnesium-Manganum-phosphoricum-Injeel
Magnesium phosphoricum D 12, D 30, D 200, Manganum phosphoricum D 12, D 30, D 200 0.183 ml each.
Magnesium-Manganum phosphoricum-Injeel forte
Magnesium phosphoricum D 6, D 12, D 30, D 200, Manganum phosphoricum D 6, D 12, D 30, D 200 0.138 ml each.

Ammonium carbonicum-Injeel
D 12, D 30, D 200 0.367 ml each.
Ammonium carbonicum-Injeel forte
D 4, D 12, D 30, D 200 0.275 ml each.

Remedy for debility, chronic rhinitis, possibly with nasal haemorrhage (when washing); congestive catarrh.

Rauwolfia-Injeel
D 8, D 12, D 30, D 200 0.275 ml each.
Rauwolfia-Injeel forte
D 4, D 8, D 12, D 30, D 200 0.220 ml each.

Lowers blood pressure in hypertonia.

Tetracyclin-Injeel
D 12, D 30, D 200 0.367 ml each.
Tetracyclin-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.

All tetracyclines have structures based on a naphthacene skeleton (chlortetracycline. oxytetracycline, 6-dimethylchlortetracycline,alpha-6-desoxy-5-hydroxytetracycline (= doxycycline)).

Indications

See under Doxycyclin-Injeel.

Calcium silicicum-Injeel forte
D 6, D 10, D 30, D 200 0.275 ml each.

Remedy for glandular disorders, disturbances of development; for weak patients with great sensitivity to cold and wet.

Papaverinum-Injeel
D 12, D 30, D 200 0.367 ml each.

Myosis, dry skin.

Hydrastis-Injeel
D 12, D 30, D 200 0.367 ml each.
Hydrastis-Injeel forte
D 4, D 12, D 30, D 200 0.275 ml each.

Remedy for affections of the mucosa: thick, viscous, ropy, yellowish-white secretions from all mucous membranes (nose, paranasal sinuses, uterus, bladder, etc.), aphthous stomatitis, menorrhagia, metrorrhagia, haemorrhagic myomas.

Dupuytren-Nosode-Injeel
D 12, D 30, D 200 0.367 ml each.
Dupuytren-Nosode-Injeel forte
D 8, D 12, D 30, D 200 0.275 ml each.

Induration and contraction of the palmar aponeurosis with development of tough cords and nodules (dosage: 1 ampoule weekly to be infiltrated locally in the region of the hardened, contracted tendons of the flexor of the finger in question. In addition, long-term therapy with Graphites-Homaccord (8-10 drops twice daily), alternating with Arnica-Heel (also 8-10 drops twice daily).

Based on the causal and conventional genetic relationship, also experimentally in Peyronie’s disease.